These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8714595)

  • 1. A general progress curve method for the kinetic analysis of suicide enzyme inhibitors.
    Wimalasena K; Haines DC
    Anal Biochem; 1996 Feb; 234(2):175-82. PubMed ID: 8714595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicide inactivation of peroxidase by H2O2: kinetic equations for peroxidatic oxidation reaction of guaiacol and determination of the kinetic parameters.
    Moosavi Movahedi AA; Nazari K; Ghadermarzi M
    Ital J Biochem; 1999 Mar; 48(1):9-17. PubMed ID: 10354950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic reaction of silent substrates: kinetic theory and application to the serine protease chymotrypsin.
    Case A; Huskey WP; Stein RL
    Biochemistry; 2003 Apr; 42(16):4727-32. PubMed ID: 12705836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of enzyme inactivation under second-order conditions by use of substrate-to-product progress curves: application to the inhibition of trypsin by alpha-1 proteinase inhibitor.
    Ozer I
    Anal Biochem; 1998 Nov; 264(2):199-203. PubMed ID: 9866683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of enzyme kinetic parameters based on statistical learning.
    Borger S; Liebermeister W; Klipp E
    Genome Inform; 2006; 17(1):80-7. PubMed ID: 17503358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescence resonance energy transfer method for measuring the binding of inhibitors to stromelysin.
    Epps DE; Mitchell MA; Petzold GL; VanDrie JH; Poorman RA
    Anal Biochem; 1999 Nov; 275(2):141-7. PubMed ID: 10552897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design.
    Murphy DJ
    Anal Biochem; 2004 Apr; 327(1):61-7. PubMed ID: 15033511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of isotope-dilution phenomenon to advantage in the determination of kinetic constants Km and Kcat for BamHI restriction endonuclease: an empirical and iterative approach.
    Roy KB; Vrushank D; Jayaram B
    Anal Biochem; 1994 Jul; 220(1):160-4. PubMed ID: 7978240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy).
    Van LM; Heydari A; Yang J; Hargreaves J; Rowland-Yeo K; Lennard MS; Tucker GT; Rostami-Hodjegan A
    J Psychopharmacol; 2006 Nov; 20(6):834-41. PubMed ID: 16478752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple method for determining kinetic constants of slow, tight-binding inhibition.
    Wang ZX
    Anal Biochem; 1993 Sep; 213(2):370-7. PubMed ID: 8238913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of continuous over batch reactors for the kinetic analysis of enzymes inhibited by an unknown substrate impurity.
    Gallifuoco A; Alfani F; Cantarella M
    Biotechnol Bioeng; 2002 Sep; 79(6):641-6. PubMed ID: 12209811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress curve analysis for enzyme and microbial kinetic reactions using explicit solutions based on the Lambert W function.
    Goudar CT; Harris SK; McInerney MJ; Suflita JM
    J Microbiol Methods; 2004 Dec; 59(3):317-26. PubMed ID: 15488275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two potent suicide substrates of mushroom tyrosinase: 7,8,4'-trihydroxyisoflavone and 5,7,8,4'-tetrahydroxyisoflavone.
    Chang TS
    J Agric Food Chem; 2007 Mar; 55(5):2010-5. PubMed ID: 17295516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
    Garcia E; Hasenbank MS; Finlayson B; Yager P
    Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrostatic channeling of substrates between enzyme active sites: comparison of simulation and experiment.
    Elcock AH; Huber GA; McCammon JA
    Biochemistry; 1997 Dec; 36(51):16049-58. PubMed ID: 9405038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for determining kinetic parameters of dissociating enzyme systems.
    Wang ZX
    Anal Biochem; 1998 Nov; 264(1):8-21. PubMed ID: 9784182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2.
    Scandura JM; Zhang Y; Van Nostrand WE; Walsh PN
    Biochemistry; 1997 Jan; 36(2):412-20. PubMed ID: 9003194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical validation of the substrate depletion approach to determining kinetic parameters.
    Nath A; Atkins WM
    Drug Metab Dispos; 2006 Sep; 34(9):1433-5. PubMed ID: 16751261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.